Antiva Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Antiva Biosciences's estimated annual revenue is currently $5.1M per year.
- Antiva Biosciences's estimated revenue per employee is $155,000
Employee Data
- Antiva Biosciences has 33 Employees.
- Antiva Biosciences grew their employee count by 57% last year.
Antiva Biosciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Medical Officer | Reveal Email/Phone |
3 | SVP, Pharmaceutical Development and Manufacturing | Reveal Email/Phone |
4 | Controller | Reveal Email/Phone |
5 | SVP Nonclinical Development and Global Health Strategy | Reveal Email/Phone |
6 | Director, Product Development and Manufacturing | Reveal Email/Phone |
7 | President & CEO | Reveal Email/Phone |
8 | Senior Virology Adviser | Reveal Email/Phone |
9 | Sr. HR Consultant/Acting Head HR | Reveal Email/Phone |
10 | Acting CFO | Reveal Email/Phone |
Antiva Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Antiva Biosciences?
Antiva Biosciences, Inc. is a clinical stage biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection. We aim to stop cancer before it starts by treating the pre-cancerous lesions caused by HPV. Our lead programs are in clinical trials in high grade anal intraepithelial neoplasias (AIN 2,3) and high grade cervical intraepithelial neoplasias (CIN 2,3). The company was founded as Hera Therapeutics in 2012 by Dr. Karl Hostetler at The University of California San Diego and builds on his anti-viral expertise as co-founder of Triangle Pharmaceuticals and Chimerix. Antiva's chemistry platform has yielded over two hundred proprietary pro-drug compounds that are designed to enhance the therapeutic index of known, potent antivirals.
keywords:N/A
N/A
Total Funding
33
Number of Employees
$5.1M
Revenue (est)
57%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in South San Francisco
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5.1M | 33 | 0% | N/A |
#2 | $7.1M | 33 | 3% | N/A |
#3 | $5.4M | 33 | 6% | $44.7M |
#4 | $9.8M | 34 | -37% | $200.9M |
#5 | $7.3M | 34 | 10% | N/A |